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SUMMARY.-The effect of varying the numbers (4,5,10,20 and40) of weekly
applications of DMBA to the dorsal skin of intact and castrate male and female
rats onthe inductionofbasal and squamous celledepitheliomas and of sarcomas
has been investigated.
Basal celled tumours originate mainly in hair follicles and squamous celled
neoplasms in the interfollicular regions of the epiderml.'s and differ in their
progression to malignancy. Penetration of the panniculus carnosus is neither
a sufficient nor necessary criterion of malignancy since growing hair follicles
pass through the muscle layer and carcinomas and sarcomas which are still
confined to the dermis, spread along theperineurallymphatics and metastasise
to the lungs.
Sex and castration do not affect carcinogenesis ofepitheliomas in the dorsal
skin at any dose level. Significantly more sarcomas result from 20 weekly
paintings in male than in female or castrate rats.
Theinductionperiodforalltumourtypes is shortenedinsensitiveindividuals
onlyby anincrease from5 to 10weeklyapplications. Forless sensitive animals
the rate of oncogenesis is accelerated with number of administrati'ons up to
20, but slowed down from this level by 40 paintings. The optimal dose for
speed of induction of all tumour types, for maximal yield of basal celled
epitheliomas and for that of sarcomas in male rats is 20 weekly applications.
The progression to malignancy varies with tumour type: it is fast for sar-
comas and slow for basal celled neoplasms. Of the 336 rats at risk only 1% have fibromas or other precursor lesions, while 40% have sarcomas; animals
with squamous celled papillomas account for 12%, but those with carcinomas
for66%; there are, however,64% of rats with basal celled papillomas and only
9% with carcinomas.
The optimal dose phenomenon in carcinogenesis is discussed.
THE incidence ofsquamous celled carcinomas ofthe skin in men is about twice
that in women (Haenszel, 1963; Miyaji, 1963). While the greater exposure of
men to environrnental factors favouring tumour development such as sunlight, occupational exposure to chemicals, injuries, may account for most of this
difference, the endocrine-related biology of the skin in males and females may play a role in the sensitivity or responsiveness to extemal carcinogenic agents. Epithelial tumours in men (Rook and Champion, 1963; Foot, 1951) originate in
hair follicles and since thereplacement oflanugo by terminal hairs in various skin
districts (face, chest, pubic region, legs, arms, etc.) is sex linked, it is not unlikely that sex hormones are involved in the prevalence of skin tumours in men. As
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of sex and the contribution of male characteristics to the enhanced risk of skin
cancer has to be investigated on induced tumours. Since the hair coat of mice
and rats does not reveal a sexual dimorphism comparable to that of man, only
smaller sex differences may be expected in these species than in men.
Berenblum (1954) states that sex plays no significant role in skin carcinogenesis
in most strains ofmice, though in some strains males are somewhat more respon-
sive than females. Most skin tumours in mice are papillomas and for the same
carcinogenic treatment and dosage a greater incidence in males than females has
been reported (Bates, 1968; Shubik, Della Porta and Spencer, 1959). Castration
ofmales(Zackheim, 1970)reduces andthatoffemalesincreasestheyieldoftumours
(Bates, 1968). Induction ofdermal sarcomas in male mice is obtained with lower
doses of carcinogens than in females (Leiter and Shear, 1943), is faster in males
(Homburger, Treger and Baker, 1963) and occurs in more males than females
(Bischoff, 1957). These reports suggest an involvement of the male endocrine
system in the greater response to carcinogenic stimulation. In other papers no
sex difference or influence of castration has been found. This may be due to
strain differences and to the use of carcinogenic doses in different solvents at or
close to the
" saturation
" point which may obscure any sex difference.
Squamous cell carcinomas are induced in a small proportion of mice by car-
cinogenic chemicals ± croton oil: 3 of 570 tumoursby Vesselinovitch and Gilman,
1957; 2 of 211 by Ritchie andShinozuka, 1967; 100 of 899byShubik, Baserga and
Ritchie, 1953; 30 to 50% by Cramer and Stowell, 1943; Terracini, Shubik and
DellaPorta, 1960;Glucksmann, 1963;Tannenbaum,VesselinovitchandSilverstone,
1964. Exceptionally a figure of 100% has been reported by Poel (1963) using
19-0 to 470 Itg. ofbenzopyrene in toluene three times a week for the life time ofthe
animals. Fewer chemicals prove carcinogenic for the skin ofrats than for that of
mice, but with DMBA the incidence of carcinomas in rats is around 80% (Glucksmann, 1963; Zackheim, 1964) with weekly applications. While basal
celled tumours are rare in mice, they occur quitefrequently in rats (Bielschowsky,
1946; Lennox, 1955; Howell, 1962) and thus the tumour types of the rat sk'
resemble those of man more closely than do those in mice. At certain dose levels
twice as many tumours are induced in rat salivarv glands ofmales than in those of
females andin males administration ofoestrogenshalves, while that oftestosterone
to females doubles the yield ofneoplasms (Glucksmann and Cherry, 1971). The
rat is thus a suitable animal for the testing of sex differences in tumour induction.
Experiments on dosage variations of chemical carcinogens have been carried
out mostly in mice and have taken one of the following forms: (1) single applica- tions of the carcinogen in various concentrations (Terracini et al., 1960); (2) repeated applications of carcinogens at varying intervals (Cramer and Stowell,
1943) or (3) ofvarious concentrations ofthe chemical over the life time ofanimals
(Poel, 1963); (4) single (Mottram, 1944; Berenblum and Shubik, 1947) or (5) repeatedapphcations of an
"initiating
" chemicalcarcinogen followedbyrepeated applications of croton oil as
" promoting
" agent for prolonged periods (30 to
50 weeks) (Berenblum, 1941; Shubik and Ritchie, 1953; Ritchie and Shinozuka,
1967; Vesselinovitch and Gilman, 1957). Even single paintings with methyl- cholanthrene (Mider and Morton, 1939) or DMBA (Law, 1941) induce tumours in
very sensitive mice. The original claim that croto"n oil has no effect if applied before the carcinogen is not supported by recent experiments (Pound and Bell,
1962; Tannenbaum, Vesselinovitch and Silverstoirie, 1964) and according to546 CORA P. CHERRY AND A. GLUCKSMANN
Shubik et al. (1959)
" tumours induced in the special initiation-promotion studies
are biologically very different from those seen in other studies employing only
purecarcinogens ".
Apart from the single administration of various doses of carcinogens, the
methods listed above are subject to the objection that treatment with either the
carcinogens or the cocarcinogens is prolonged and carried out until visible neo-
plasms appear. Thus the
" saturation point
" for maximal tumouryield may be
reachedwith doses far belowthe maximum and agreat fraction ofthecarcinogenic
stimulation may be wasted. Cramer and Stowell have pointed out that with the
exception of minimal doses required for tumour induction in the most sensitive
animals, an increase in carcinogenic dosage shortens the induction period in the
more resistant animals and does not affect that in the sensitive mice; that with
increasing dosage multiple neoplasms develop in extensive papillomatous regions,
while with low doses single carcinomas arise in a skin showing only mild degrees
ofhyperplasia; that high susceptibility to carcinogenic stimuli may be restricted
toonly a small area ofskin in an animal. Iftheperiod ofobservation is restricted
to about'50 weeks the alternative objection may be made that tumours in the
more resistant animals may not yet have appeared and that thus the total yield
oftumours obtained, may not be a true measure ofthose induced.
Terracini et al. (1960) suggest that in mice the 30% incidence of'careinomas is
maximal with a single dose of 200 ltg. of DMBA in acetone and doses of 500 and
1000,ag. induce only 10 and 19% respectively. Similarly the maximal induction
rate for sarcomas is 20% at 250 Itg. and not changed by higher doses. This
suggestion of an
" optimal
" dosephenomenon appears to besupportedby areport
of Shubik and Ritchie (1953) that in Swiss female mice painted once, twice or
three times at weekly intervals with 0-2% DMBA in mineral oil followed by
prolonged andrepeated croton oilapplications, the inductionperiod increases with
the number ofinitiating DMBA doses. The induction of a refractory state or a
necrotizing effect of the DMBA treatment has been assumed as explanation.
Subsequently Ritchie and Shinozuka (1967) and Vesselinovitch and Gilman (1957)
have found that theyield ofpapillomas increases with number ofDMBApaintings
and that there is no evidence for the induction of arefractoryperiod.
In ourexperiments we haveexplored thedosagephenomenon in carcinogenesis
by restricting the number ofweekly applications of DMBA to 5, 10 and 20 and
contrasting them with weekly applications for the life span of the animals or
until tumours appear, i.e. on the average with 40 applications as we have done in
experiments on the female genital tract (Glucksmann and Cherry, 1970a, b). In
this regime the interval between fractions and the concentration of DMBA are
constant and the dose is variedby the number offractionsapplied. This schedule
allows of a better evaluation of the doses required to induce neoplasms in the
various constituent tissues of the skin, to test for optimal dose levels and for
sex differences at variousdoses. Thisreportis concernedwiththe effect ofvarying
doses of weekly DMBA applications on the induction of squamous and basal
celled tumours and of sarcomas in the dorsal skin of intact and castrate male and
female rats.
MATERIALS AND METHODS
Intact and castrate male and female hooded rats of the Lister strain, random
bred within a closed colony in thislaboratory since 1940, were used for the experi-547 TUMOUR INDUCTION IN SKIN OF RATS
ments which extended over a period from 1953 to 1968. The rats were housed
not more than seven to a cage and given water and food pellets of MRC-diet 86
ad libitum. Only animalssurviving for at least 100days afterstarting the experi-
ment were considered at risk and the number of rats in the various treatment
groups are given in Table 1.
TABLE I.-Controls and Treatment Groups with Sex, Number of Rats and
Survival Data
Survival in days
Doses of No. of
DMBA Sex rats Range Medium
None 38 321-906 654
None 18 585-778 727
None 36 322-826 719
None 20 260-772 675
4 18 302-803 558
4 20 135-803 470
5 21 350-729 634
5 21 302-716 595
5 21 344-722 540
5 21 342-722 610
10 21 246-604 396
10 20 246-484 359
10 21 210-604 356
10 22 289-604 378
20 34 163-330 261
20 22 224-309 262
20 20 179-329 260
20 21 182-332 262
40 cT 30 188-313 261
40 y 41 22"94 330
Castration of male and female rats was performed under ether anaesthesia
at the age of 3 to 4 weeks. Carcinogenic treatment with a I 01 solution in acetone
of 9,10-dimethyl-1,2-benzanthracene (DMBA, Koch-Light Ltd or Sigma) was
started when intact and castrate animals were aged 7 to 8 weeks. The carcino-
genic solution was applied to the interseapular region of the dorsal skin without
prior clipping or shaving of the hairs. In the early experiments the solution was
distributedby means of aU-shapedpipette over the treated area; in later experi-
ments theapplication was madeby means of a cottonwool swab mounted on athin
wire rod, the swab was saturated with the solution which was distributed by a
single stroke over the treated region of skin. This procedure was repeated at
weekly intervals either for the life span of the animals (with an average of 40
applications) or restricted to 4, 5, 10 or 20 times (Table 1). In two groups of
intact males ofwhich one was treated 20 times with thepipette and the other with
the swab technique, the same incidence of tumours was obtained. This suggests that the dose of carcinogen at each application was similar for the two methods
used.
All animals were examined at weekly intervals and those with clinical signs of malignant skin tumours. or if sick or aged, were killed and a post mortem
performed. The entire treated area of skin with subcutaneous tissue was excised
and stretched on pieces of filter paper before fixation in Zenker-acetic fluid.
During the process of dehydration the skin was cut longitudinally into multiple
narrow strips to include all tumours with a stretch of adjacent epidermis. In548 CORA P. CHERRY AND A. GLUCKSMANN
addition to the skin the following tissues were fixed for histological examination:
pituitary, thyroid, thymus, liver, spleen, kidneys, adrenals, intestine, mesenteric
nodes,gonads with uteri andcervico-vaginal tract or seminal vesicles andprostate.
The material was fixed in Zenker-acetic or Bouin's fluid, processed in routine
manner, embedded in paraffin and sectioned at 6 or 8 # depending on organ;
the endocrine glands were sectioned serially. Slides were stained with
haematoxylin-eosin, the periodic acid-Schiff technique (PAS) after diastase
digestion, Van Gieson or carmalum-orange G-aniline blue.
Calculation of results
With few weekly applications and thus low doses of the carcinogen generally
onlysingle tumours are induced and the rest ofthe treated skin ismacroscopically
and microscopically normal. With ten or more doses individual rats have
macroscopic and microscopic papillomata as well as extensive papillomatous
hyperplasia ofthe epidermis and multiple skin cancers which may have arisen by
confluence offoci. It is thus difficult to assess accurately the number of tumours
in individual animals. In the analysis the most advanced lesion was the criterion
used in the classification oftumour-bearing rats. When animals had more than
one distinct type of neoplasm they were recorded separately under sarcomas,
squamousepitheliomas and basal celled tumours.
For the age-specific induction rates the percentage of tumour-bearing rats
amongst those at risk for consecutive 100-day periods was plotted at the 50-day
interval.
The survival data in Table Igives the age indays at death ofthe first and last
animals in each group with median age; the duration ofthe experimentalperiods
can be calculatedbydeducting 60 days from thesefigures.
Incidenceofskin tumours outside thepa'inted area,ofbreast tumour8andofleukaemia
Contro18.-Intact and castrate male andfemale rats ofourcolonyhave survived
forperiodsranging from 260 to 906 days (Table1). Spontaneousskintumoursdo
not occur in any ofthe four groups and breast tumours do notdevelop in the males
or in the spayed females. In the intact females their incidence is 8% (Table 11)
TABLE II.-Incidence ofSkin Tumour8 Outside the Painted Area, ofBreast
Tumour8and ofLeukaemia
Skin tumours Breast tumours Leukaemia
Doses of NO. of __'. ( A ---
DMBA Sex rats No. % No. % No. %
None cl 38 0 0 0 0 11 29
None 18 0 0 0 0 2 11
None 36 0 0 3 8 5 14
None 20 0 0 0 0 5 25
4 18 0 0 0 0 0 0
4 20 1 5 2 10 0 0
5 c. 21 2 10 2 10 1 5
5 21 2 10 0 0 2 10
5 21 0 0 8 38 4 19
5 21 1 5 0 0 2 10
10 21 1 5 0 0 2 10
10 20 0 0 0 0 I 5
10 21 2 10 I 5 0 0
10 22 0 0 0 0 8549 TUMOUR INDUCTION IN SKIN OF RATS
and they have been found in rats surviving for at least 590 days. The type of
leukaemia in controls has been described previously (Glucksmann and Cherry,
1968). Theincidencevariesfromll%to29%andthediseaseismanifestclinically
between 321 and 770 days of age.
Skin tumours.-Solitary tumours appeared on the skin outside the painted
interscapularregion in nine ofthe 374experimental animals andonly inthosegiven
ten or fewer applications of DMBA (Table 11). Six rats had squamous celled
carcinomas of which five arose on the face and one (CT x 5DMBA) on the hind
leg. In three animalsgiven fiveapplications ofDMBAbenignneoplasms occurred
on the ear; a squamous papilloma in a castrate male, a melanoma in an intact
male and one in aspayed female.
In the groups treated four or five times with the carcinogen these epidermal
tumours occured late, i.e. 574 to 657 days after the first painting. In the 3
rats given 10 doses the carcinomas were manifest clinically after 150, 248 and
325 days.
Breast tumour8developed only in the groups given 4 to 10 weekly applications
of DMBA to the dorsal skin in which the majority of animals survived for long
periods (Tables I and II). While none occurred in the castrate females, two
intact males had breast tumours, one an adenocarcinoma and the other a fibroma
and they were found in rats aged 679 and 688 days. In two groups of intact
females the incidence of these neoplasms is similar to that in the controls while
in a third group it is muchhigher (38%). In otherdose-responseexperiments for
the induction ofcervico-vaginal tumours and carried out at about the same time
as the present series, the incidence of breast tumours in intacts given 5, 10 or 20
doses of DMBA was 40%, 33% and 19% respectively with corresponding median
survival times of 561, 645 and 393 days. The lower incidence ofthese neoplasms
with the highest dose may be accounted for by the shorter survival time ofthese
animals.
Leukaemia.-The type and incidence ofthe disease is the same in controls and
experimental animals and varies from 0% to 36% (Table II) with an age range of
210-626 days. In addition to the animals listed in the table, one intact female
painted 20 times had leukaemia. There is no obvious influence of sex, castration
and treatment with carcinogens on leukaemogenesis.
RESULTS
Definition ofmalignancy
For over 50 years the invasion or penetration of the panniculus camosus has
been and still is accepted as the main criterion of malignancy for epithelial skin
tumours in rodents (Roe, Peto, Kearns and Bishop, 1970). It is assumed that
normal epidermal structures and benign tumours are not found at this depth and
thatonlyfewtumourswith definite cvtolovical andhistologicalsigns ofmalignancy
are seen above the dermal muscle (Roe etal., 1970). Neither oftheseassumptions
is entirely correct.
In anagen hair follicles penetrate the panniculus carnosus (Fig. 1) or protrude
through gaps in the muscle. Similarly benign papillomata may extend into and
through the muscle layer. Squamous celled carcinomas arise in the hyperplastic
epidermis, in abnormal hair follicles or most frequently in papillomatous lesions
within the dermis. They do not change their biological, cytological or histo-550 CORA P. CHERRY AND A. GLUCKSMANN
logical features on penetrating the panniculus carnosus and appear exactly the
same above andbelowit. Theyinvadethenormal structures ofthe dermis asthey
do those of the subcutis and evidence of their malignancy is provided by the
admittedly rare instances ofmetastasis to thelung of a squamous celled carcinoma
still restricted to the dermis (Fig. 2 and 3). Invasion oftheperineurallymphatics
by carcinomas still confined to the dermis is a more frequent occurrence and also
evidence ofmalignancy (Fig. 4, 5 and 6). Carcinomas within the dermis are not
rare, ifthe animals are killed as soon as a definite clinical diagnosis ofmalignancy
can be established, as is our practice. Thus 42% of 224 squamous celled car-
cinomas ofthe rat skin and 41% ofthose in mice are still restricted to the dermis.
Penetration of the panniculus carnosus is obviously neither a sufficient nor a
necessary criterion ofmalignancy for skin carcinomas in rodents.
Basal celled tumours of the dorsal skin like those of the vulva (Glucksmann
andCherry, 1970b) are derivedmainly from hair follicles and like them in anagen,
they grow as papillomas within an intact and usually thick basement membrane
through the dermis (Moffat, 1968). They do not elicit an inflammatory reaction
at this stage and merely push aside the normal dermal structures. Malignant
basal celled epitheliomas are recognized by abnormalities and variability in
cytological features, a high rate of mitosis, by the penetration of the basement
membrane and the proliferation of individual cells and strands of them in the
dermis and subeutis.
Hypertrophy, hyperplasiaandadenomas of sebaceous glands are seen in almost
all rats treated with ten or more doses of DMBA at weekly intervals. These
tumours as well as three adenocareinomas of sebaceous origin in our series have
been omitted from the quantitative evaluation of our findings. Squamous celled
tumours with admixtures of sebaceous origin and those containing a basal celled
strain are recorded as squamous celled tumours. Trichoepitheliomas are counted
as basal celled tumours since the latter too derive mainly from hair follicles in the
rat.
Sarcomas arise eitherindependentlyinthe dermis orin the stroma ofepidermal
tumours which often shows a sarcomatous reaction. Independent growth away
from theepitheliallesion, increasedcellularity and rate ofproliferationdistinguish
sarcomas from the sarcomatous changes in the stroma ofepitheliomas. Most of
the sarcomas arefibrosarcomas,thoughosteochondrosarcomas,myxofibrosarcomas,
I
EXPLANATION OF PLATES
FIG. I.-Normal hair follicle in the rat skin penetrating the panniculus carnosus (p) by
pushing between muscle fibres. PAS x 140.
Fia. 2.-Squamous celled carcinoma in the dorsal skin of a castrate male rat painted 10
times at weekly intervals with DMBA and killed 270 days after the first application. The
tumour is confined to the dermis and does not touch the panniculus carnosus (p), but has
metastasized to the lung. H. and E. x 27.
FIG. 3.-Lung metastasis from the squamous celled epidermal carcinoma illustrated in Fig. 2.
H. and E. x 36.
FIG. 4.-Squamous celled carcinoma in the dorsal skin of a castrate male rat painted 10
times at weekly intervals with DMBA and killed 367 days after the first application. The
tumour is still confined to the dermis and does not touch the panniculus carnosus (p).
The diffuse spread of the carcinoma within the dermis (a) and in the perineural lymphatics
(b) is illustrated in Fig. 5 and 6. H. and E. x 27.
FiG. 5.-Part of the tumour (a, in Fig. 4) at higher ma ification. H. and E. x 140.
FIG. 6.-The perineural lymphatie, (b in Fig. 4) is d by tumour cells, one of which is in
mitosis. H. and E. x 750.BRITISH JOURNAL OF CA-NCER. Vol. XXV, No. 3.
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haemangioendotheliosarcomas and cellulartypeswithgiantcells occuroccasionally.
The sarcomas too tend to invade the perineural lymphatics and to spread along
them.
Squamou8 celled tumour8
The histogenesis ofepidermal tumoursproceeds viahyperplasia and radication
of interfollicular regions to the formation of papillomas which project from the
surface or intrude into the dermis or do both. Malignant changes occur in the
papillomatous regions, usually in intruding papillomas or in merely hyperplastic
skinregions. With ten and moreweeklyapplications ofDMBA thepaintedregion
is usually covered by multifocal papillomas which tend to become confluent.
Malignant change is also very frequently multifocal and leads to the formation of
apparently single carcinomas by confluence. It is impossible to assess with any
degree of accuracy the number of papillomas in even serial sections of the skin,
since they are so numerous and their borders are so ill-defined one from another.
For this reason only animals with tumours are recorded rather than the number of
tumours per rat which is at best only an approximation and certainly an under-
statement of their original number, i.e. before their confluence to a
" unit
" of
macroscopic dimensions. In all individuals given ten or more paintings very
numerous papillomas are present in addition to single or multiple carcinomas.
With five weekly doses of IDMBA there are usually only single papillomas or car-
cinomas in an epidermis which is only moderately hyperplastic. These findings
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FIG. 7.-Pereentage of squamous celled papillomas and carcinomas of the dorsal skin in intact
(d) and castrate (,S-) male and female (?,-fl rats induced by 5, 10, 20 or 40 weekly doses of DMBA.552 CORA P. CHERRY AND A. GLT-TCKSMANN
are in full agreement with the statement by Cramer and Stowen (1943) that
i
mice smaller doses of carcinogens indirce only single tumours in a fairly normal
skin whilelarger doses elicit multiple tumours in apapillomatousepidermis.
Thetotalincidence ofanimalswithsquamous ceRedpapillomas or carcinomasis
recorded in Fig. 7 for intact and castrate male and female rats given 5, 10, 20 or
40weekly doses ofDMBA. Male and female ratspainted with DMBA four times
at weekly intervals have failed to produce any skin tumours and any noticeable
abnormahty ofthe skin in over 2 years ofobservation. With five weekly doses a
number ofanimals have reacted with tumours, some even with carcinomas. The
incidence is, however, very much lower than in the groups given ten or more
appheations which have not only more tumour bearing animals, but also more
tumours per animal and a much higher proportion of carcinomas to papillomas,
%
x2O x4O x10
80-
40-
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0 200 Days 400 600
FIG. 8.-Cumulative incidence of squamous celled neoplasms (papillomas + carcinomas) in male
(CT) and female (?) rats induced by 5, 10, 20 or 40 weekly applications of DMBA.
i.e. in a higher proportion of rats the skin has advanced to the malignant state in
the process of careinogenesis. There are no significant differences in these three
treatment groups as to incidence of squamous celled tumours, proportion of
papillomas to carcinomas or with sex or castration of the animals (Fi'g. 7). It is
noteworthy that in the great majority of rats painted ten or more times careino-
genesisprogresses to fullmalignancywhilein micegiven asinglepaintingofDMBA
followed by frequently repeated paintings with croton oil only about 11% of
the induced skin tumours become malignant (Shubik, Baserga and Ritchie,
1953).
The rate of cumulative increase in incidence of squamous celled tumours of
which the majority are carcinomas is plotted for intact male and female rats in553 TUMOUR INDUCTION IN SKIN OF RATS
Fig. 8. The incidence is almost identical and since the castrate male and female
animals behaveidentically asregards cumulative incidence oftumours, the curves
for them are omitted. In all four groups the rate of tumour induction increases
with number of DMBA doses up to the 20 dose level, but actually slows down
subsequently with 40 doses in intact animals. The optimal dose phenomenon in
tumour induction is also revealed if the age-specific tumour incidence is plotted
for intact males (Fig. 9) or intact females (Fig. 10). Since the experiment with
40 doses of DMBA given to females has been repeated at an interval of 5 years
with identical results and that with 20 doses to males at an interval of 4 years,
the findings of an optimal dose for skin tumour induction can beregarded as well
established.
80-
40-
&.01-
0 200 400 600
Days
FIG. 9.-Age-specific induction rates of squamous celled tumours in intact male rats for
5, 10, 20 or 40 weekly doses of DMBA.
Increasing the carcinogenic dosage shortens the induction period only for the
less sensitive animals (Cramer and Stowell, 1943) but does not affect that of the
most sensitive individuals. This phenomenon is clearly seen in Fig. 8-10, where
thespread forthe appearance ofthe first tumours in ratspainted ten or more times
is much smaller than that for the last tumours to appear, i.e. in the least sensitive
individuals. With five paintings only the most sensitive rats develop tumours
and these appear muoh later than with the greater number of DMBA adminis-
trationsin allfourgroups ofanimals. The differencesintheincidence ofsquamous celled tumours between males and females and intacts and castrates areprobably due to the chance distribution in the groups ofparticularly sensitive rats (Fig. 7). Such a chance difference in the presence ofsensitive animals may also account for554 CORA P. CHERRY AND A. GLUCKSMANN
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FiG. IO.-Age-specific induction rates of squamous celled neoplasms in intact female rats
painted 5, 10, 20 or 40 times with DMBA at weekly intervals.
the fact that no tumours are obtained with four weekly doses and some 30%
with five weekly doses. In mice a single application of a carcinogenic hydro-
carbon may elicit tumours in sensitive animals and it seems probable that such a
result may be obtained also with very sensitive rats.
Ba8al celled tumoum
The majority of papilloma arise in isolated and usually not adjacent hair
follicles and grow within their base'ment membrane andadjacent connective tissue
sheath. Individual foci are separated by the relatively large interfollicular
areas of skin and because of their separation and manner ofexpansion have less
tendency to become confluentthan squamous celledpapillomas orfoci. Neverthe-
less multiple, but widely spaced basal celled papillomas are found in most rats.
Thoughthey couldbeenumerated, we have adhered to the evaluation ofnumber of
rats with tumours as for squamous neoplasms rather than to give an estimate of
number ofbasal ceRed tumours per rat. Relatively few of theneoplasms become
malignant (Fig. I1) when they burst through their basement membranes and
connective tissue sheath and tend to become confluent.
The total incidence of tumours increases with number ofpaintings up to and
including the x 20 level and subsequently drops significantly by 20% ± 9-3 in
males and 16% + 7-9 in females. Malignant conversion is low with five doses
but rises to about the same level with more numerous applications of DMBA.
The rate of tumour development accelerates with increasing number of doses up
to 20, but slows dow-n with 40 paintings (Fig. 12). The same optimal rate isTUMOUR INDUCTION IN SKIN OF RATS 555
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FIG. 1l.-Percentage of basal celled papillomas and carcinomas of the dorsal skin induced in
intact (d) and castrate males and females by 5, 10, 20 or 40 weekly doses of DMBA.
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FIG. 12.-Cumulative incidence of basal celled neoplasms (papillomas and carcinomas) in xna,je and female rats painted 6, 10, 20 or 40 times with DMBA at weekly intervals.
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seen in the age-specific plots of careinogenesis for males (Fig. 13) and for females
(Fig. 14). There is very little difference in rate of tumour development for 10
and 40 doses ofDMBA, while 20 doses accelerate and increase tumour formation
above this level. There is no difference with sex or castration for the same number
of doses either as regards speed or incidence of basal celled neoplasms, nor is
there any consistent variation in the proportion of carcinomas to papillomas with
sex (Fig. II). A similar optimal dose of 20 paintings for total incidence and rate
ofinduction ofbasal celled tumourshasbeenfoundinthevulvaofrats(Glucksmann
and Cherry, 1970b) and this pattern has not been affected by treatment witli
thy-roactive compounds. At this site, however, the proportion of carcinomas to
papillomas is significantlv -areater with 20 than with 40 doses.
x2O X10
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Fic.. 13.---Age-specific induction rates of basal celled tumours in intact males for 5, 10,
20 or 40 weekly doses of DMBA.
Sarcomas
There is usually only a single sarcoma per rat though this fact does iiot
necessarily imply origin in a single focus or cell. As at other sites such as the
cervico-vaginal tract (Glucksmann and Cherry, 1970a) or the salivary glands
(Glucksmann and Cherry, 1971) the histological type of the tumour varies from a
well differentiated fibrosarcoma to an anaplastic cellular tumour and may also
entail a component of osteochondrosarcoma, myxofibrosarcoma or haemangio-
endotheliosarcoma. The presence of multiple components in the same neoplasm
may be due to a multicellular or multifocal origin, i.e. the carcinogenic treatment
affects avariety oftissues or cells, oralternatively to apluripotentiality ofaffected
sarcomatous cells which subsequently diverge in their differentiation or attempt
at differentiation according to the environment. There is at the moment not557 TUMOUR INDUCTION IN SKIN OF RATS
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FIG. 14.-Age-specific induction rates of basal celled tumours in intact females for 5, 10, 20 or 40 weekly doses of DMBA.
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FIG. 15.-Percentage of dermal sarcomas of the dorW skin induced in intact and castrate males and females by 5, 10, 20 or 40 weekly applications of DMBA.558 CORA P. CHERRY AND A. GLUCKSMANN
sufficient evidence to distinguish between these possibilities. In the salivary
glands particularly, and to a great extent also in the cervico-vaginal tract, the
variation in type of induced sarcomas is much greater than in the dorsal skin,
where themajority oftumours (i.e,. 126 of133) are fibrosarcomas ofvaryingdegree
of maturation. The remaining 7 tumours are: 5 osteochondrofibrosarcomas, I
myxofibrosarcoma and I haemangioendothehosarcoma. There is no clear
correlation oftumourtype withDMBAdosage orwith sex oftherats.
The histogenesis of the dermal sarcomas like that of the cervico-vaginal tract
progresses only very rarely via the stage of a fibromatous precursor lesion. In
the 336 rats at risk fibromas are present in only three animals (I%) as against 133
with sarcomas (40%) and there is also one case ofhaemangioma. Many sarcomas
ariseinthe stromaofsquamouscelledneoplasms,butothersoriginateindependently
ofepitheliomas in the dermis. The precursor lesions in the form ofcellularity of
the tumour stroma arefairlyrare,presumablybecauseunliketheepithelialtumours
the connective tissueneoplasms progressrapidly to themalignant state. Because
ofthe s'carcity offibromas and precursor lesionsthey have been omitted from the
quantitative evaluation.
The incidence of sarcomas increases up to 20 weekly doses ofDMBA and then
faRssignificantly in the case ofintact males and less so in intact females (Fig. 15).
The increase from 5 to 10 and 20 applications is significant if all rats thus treated
are considered (Table III). While sex differences are not significant at 5, 10 and
40paintings, at 20 dosessignificantly more males than females have sarcomas and
the castrate rats have fewer than theirrespective intact sex (Fig. 15). The rate of
tumour formation isoptimal at x 20 DMBAand, as with theepithelialneoplasms, that at 40 doses is about the same as for ten (Fig. 16). A suggestion of sex differ-
ence for intact males and females is seen in the age-specific plot of sarcomas: at
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FIG. 16.-Cumulative incidence of dermal sarcomas in male and female rats painted 5, 10, 20 or 40 times with DMBA at weekly intervals.559 TUMOUR INDUCTION IN SKIN OF RATS
80-
x2O
X40
X10
40-
x5
0 200 400 600
Days
FIG. 17.-Age-specific induction rates of dermal sarcomas m intact rnales for 5, 10, 20 or 40 weekly doses of DMBA.
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FiG. 18.-Age-specific induction rates ofdermal sarcomas in intact females for 5, 10, 20 or 40 weekly doses of DMBA.560 CORA P. CHERRY AND A. GLUCKSMANN
TA13LEIII.-Incidence ofSquamou8Celled Tumour8 and ofSarcoma8for
Different DOW of DMBA
Squamous celled Basal celled
No. at tumours Sarcomas tumours
DMBA Sex risk % % %
* 40 71 96+2
- 3 55±5-9 73±5- 3
* 20 97 99±1.0 66±4- 8 92±2- 8
* 10 84 96±2-1 27±4- 8 85±3-9
x 5 84 24±4-7* 8±3- 0 31+5-1
Carcinomas only: 5 2
- 4.
all doses ofDMBA there is a rise in percentage to about 80% in males and to only
about 40% in females (Fig. 17 and 18). The cumulative percentage shows this
difference only at 20 weekly doses ofDMBA (Fig. 16), and the same is true for the
dose-response curve (Fig. 19). For the same incidence of squamous celled car-
cinomas in intact males and females, the percentage of induced sarcomas is only
about halfthat ofepitheliomas except for intact malespainted 20 times.
The relative proportion of carcinomas to sarcomas varies by a factor of 1-5 to
3-5 for different treatment regimes and of 2 (265 squamous celledpapillomas plus
carcinomas to 133 sarcomas) for the whole series. Most of the epitheliomas are
malignant (Fig. 7) except for the lowest dose (Table 111) when an incidence of5%
carcinomas is notreallydifferent from that of 8% sarcomas. The totalpercentage
of carcinomas is 66% (224 rats with squamous celled carcinomas) as against 40%
for sarcomas (133 rats with sarcomas), i.e. a factor of about 1-7.
DISCUSSION
In rats sex has asignificant influence on the induction of sarcomas in the dorsal
skin by 20 paintings with DMBA. Tumour formation occurs more frequently in
males than in females or castrates (Fig. 16-19) and this sex difference parallels
that in man (Haenszel, 1963; Miyaji, 1963; Rook and Champion, 1963) and mice
(Bates, 1968; Shubik et al., 1959; Zackheim, 1970; Leiter and Shear, 1943;
Homburgeretal., 1963;Bischoff, 1957). Asexpected from the absence of a dimor-
phism in the hair coat of rats, no sex difference in the induction of epithelial
tumours comparable to that in man is seen at least in the dorsal region and Nvith
the dose regime employed. In the vulval skin of rats castration enhances the
progression to malignancy of squamous celled tumours elicited by five and ten
weekly paintings with DMBA (Glucksmann and Cherry, 1970a), but consistently
reduces the incidence ofbasal celledneoplasms at all dose levels ofDMBA. With
40 paintings, for instance, there are 44 basal celled epitheliomas in 64 intacts
(69%), but only 9 in 36 castrates (25%). The relation of these tumours to hair
follicles willbe discussedlater. Theseobservationsindicatethat sexhormonesmay
affect carcinogenesis in the skin, that they are effective under varying conditions
ofstimulation and vary with the component tissues andregions ofthe skin. They
represent only one of the many interacting factors involved in the induction of
neoplasia.
Theproportions ofbenign tomalignant lesions in the rat skin varygreatly with
the tissue oforigin ofthetumours; benign precursor lesions and fibromas are rare
(about I%) compared with sarcomas (about 40%)suggesting arapidprogression to
malignancy. At all dose levels basal celled papillomas predominate, i.e. in
214 or 64% of 336 rats at risk, while carcinomas are relatively rare, i.e. in 30 of5.61 TUMOUR INDUCTION IN SKIN OF RATS
336 animals or 9%. In the same group ofrats 224 have squamous celled carcino-
mas (66%) and 41 papillomas (12%). These figures are based on the presence of
the most advanced lesion in an individual and those with carcinomasusually have
papillomas and those with sarcomas may have occasionally less advanced lesions
as well. The total incidence of tumours in these rats increases from 40% with
sarcomas, to 73% with basal celled and 78% with squamous celled epitheliomas.
In rats the squamous celled tumours arise mainly from the interfollicular areas of
theepidermis which arelargerthan in mice because ofthe differences inthedensity
ofthepelage: rats have fewer but coarserhairs per unit area, while mice have more
and finer hairs, and thus relatively less interfollicular epidermis. In mice hair
follicles and interfollicular regions participate in the for'mation of squamous
papillomas and carcinomas and thegrowth rate ofpapillomas varies with the hair
cycle (Jonkhoff, 1928; Glucksmann, 1945; Wolbach, 1951; Borum, 1965). In rats
hair follicles and the interfollicular regions of the epidermis are not as closely interwoven as in mice, react more independently of one another and give-rise to
different tumour types. Basal celled tumours in mice are rare (Lennox, 1955;
Bielschowsky, 1946) and in our series amount to merely 4%; in rats they arise. in
hair follicles (Howell, 1962; Dobson, 1963) preferentially. It is interesting to
speculate whether the relatively lower rate of progression to malignancy of
squamous celled tumours in mice and ofbasal celledepitheliomas in rats is linked
to their origin in hair follicles. It is not known whether carcinogenesis or rate of
growth ofrat tumours is affectedby the hair cvcle as it is in mice.
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FiG. 19.-Dose-response curve for the induction of squamous celled carcinomas and of dermal
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Carcinogenic dosage affects (1) the yield of tumours, i.e. how many animals
respond with neoplasia and how many neoplasms are induced per animal; (2)
theprogressiontomahgnancyofsuchprecursorlesions aspapillomas andfibromas;
(3) the speed at which tumours are induced particularly in the less susceptible
animals. The structural elements of the dorsal skin of rats, i.e. epidermis, hair
follicles and appendages and dermis respond differently to changes in dose level
as regards the three parameters mentioned and the differences are most marked
for the less susceptible rather than the sensitive animals of a group as already
pointed outby Cramer and Stowell. Our series appears to show a threshold dose
offiveweeklypaintings, since notumourshavebeenelicitedbyfourweeklyapplica-
tions of DMBA. This result is probably fortuitous in the sense that none ofthe
rats painted four times have been sensitive. It seems likely that as in mice a
single appheation may elicitneoplasia in a very sensitive individual.
Near the threshold dose (five weekly applications ofDMBA) the incidence of
tumours is low, i.e. restricted to the most sensitive animals; there is usually only
one neoplasm present at a time; very few -tumours are malignant and even the
first tumours appear very late. Doubling the number ofweekly doses increases
the yield of squamous celled (Fig. 7-10, Table III) and basal celled tumours
(Fig. 11-14, TableIII) to almostthe maximallevel and alsothenumberoftumours
per animal, while sarcomas do not reach so high a level of incidence (Fig. 15-18,
TableIII). Theprogression tomalignancy isjust short ofmaximal for squamous
celled carcinomas (Fig. 7) and about maximal for basal celled tumours (Fig. 11).
The inductionperiodforthe first tumour ofanytype isconsiderably shortened and
equals that in rats treated 20 or 40 times (Fig. 8, 12 and 16).
For the less sensitive animals the incidence of sarcomas and the proportion of
squamouscelled,lcarcinomasis maximal at 20 doses and so isthespeedofformation
of all three tyJ*s of tumours, but is slowed down with increasing the number of
weeklypainting to 40 (Fig. 8, 12 and 16). The different sensitivity ofindividual
members ofthe various treatment groups is shown clearlyby.-the almost identical
duration of the induction period for the first and the spread in time for the last
tumours to appear at the three higher dose levels (Fig. 8-10, 12-14 and 16-18).
This confirms that increase in carcinogenicdosage affectsmainly the less sensitive
animals andshortenstheinductionperiodinthemsignificantly aswell asincreasing the tumouryield.
Increases in incidence and rate of tumour formation are brought about by higher carcinogenic dosage and for the same dosage, by various chemical and
physical factors. Sarcomas are more frequent in intact males than in females or
castrates at 20 treatments (Fig. 15 and 19). The rate of induction of cervico-
vaginal sarcomas in castrate rats is enhanced and speeded up by the adminis-
tration OfL-thyroxine, methylthiouracil, insulin, alloxan-induced diabetes, pelvic
or whole body X-irradiation (Cherry and Glucksmann, 1960, 1970). Cortisone
applied with a carcinogen during the growthphase ofthe hair cycle increases the
incidence ofepitheliomas ofthe dorsal skin in mice and so doeSL-triiodothyronine irrespective of the hair cycle (Sherwin-Weidenreich et al., 1959; Weidenreich-
Sherwin and Herrmann, 1964). Thus the sensitivity to carcinogenic stimulation
can be increasedbysystemic factors and also reduced as for instance the incidence
of basal celled tumours of the vulva in castrate rats by methylthiouracil (Glucksmann and Cherry, 1970b) or that of cervico-vaginal sarcomas in intact
and castrate rats by large doses ofoestrogens (Glucksmann and Cherry, 1968).TUMOUR INDUCTION IN SKIN OF RATS 563
At 40 treatments the rate of formation of all three types of tumours is slowed
down, the incidence of sarcomas in intact males and that of basal celledepithelio-
mas for all rats is significantly reduced compared with 20 weekly doses of DMBA
(Table 111). Thus the latter regime is
" optimal
" for tumour induction-a
phenomenon observed in chemical carcinogenesis for epithelial tumours of the
cervico-vaginal tract of rats (Glucksmann and Cherry, 1970a and b), in radiation
carcinogenesis of ovarian and thyroid tumours and of lymphomas (Upton, 1961)
and specifically for skin tumours (Henshaw et al., 1949; Hulse, 1967). In all
these instances an increase above a critical level of a single or ofrepeated carcino-
genic stimuli reduces either the incidence of tumours or the rate oftheir formation
or both, thus reversing the trend of shortening the induction period, increasing
the tumour yield and enhancing malignant progression with increasing dosage.
The favoured explanation of this phenomenon assumes that at lower levels of
dosage an initiating or inducing effect of the carcinogen predominates, but is
counteracted at higher levels by its inhibitory, sterilizing or lethal effect on the
same target cell(s) (Shubik and Ritchie, 1953; Gray, 1965; Hulse, 1967). Ritchie
and Shinozuka (1,967) have subsequently found no evidence for the induction of
a
" refractory
" period by the initial DMBA-painting; Sherwin-Weidenreich et al.
(1959) report that thegreater initial ulceration, scarring and disturbed hairgrowth
following the application of DMBA during the resting phase or in cortisone-
treated miceduring thegrowth phase ofthe hair cycle results in increased careino-
genesis; epithelial hyperplasia of the cervico-vaginal tract of rats persists in spite
of continued treatment with DMBA and in the absence of tumour formation.
The evidence for an action on the target cells themselves which counteracts the
carcinogenic effect is thus not very convincing and does not account for the mere
slowing down of the carcinogenic process in the less susceptible animals.
The morelikelyexplanation ofthe optimal dose phenomenon is that the target
cells as well as their environment (dermis and supporting structures for epithelial
skin tumours, blood vessels and migratory cells as well as interaction with the
epithelial formations in the case ofsarcomas) are affected by the carcinogens and
their interaction promotes or inhibits neoplasia. In the case of large single doses
of for instance irradiation, slowly developing changes linked with progressive
endarteritis obliterans and periphlebitis during the long induction periods
(Glucksmann, 1967) modify carcinogenesis, while with fractionated treatmeiits by
chemical carcinogens changes in the parenchyma and stroma are induced which
in their interaction may modify the response of the target cells to the later car-
cinogenic stimuli. There are also subtler changes in blood flow, inflammatory
reaction, etc., which together with hormonal and other systemic influences in
varying combinations at different dose levels influence neoplasia in response to
carcinogenic agents which affect both the exposed cells and their environment.
The consideration of
" the
" target cell in isolation from its interaction with other
organs and tissues is theprerogative ofthe merely numerate theorist but anathema
to the biologist.
The authors are indebted to Mr. G. C. Lenney, A.I.S.T., for the illustrations.
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